Abstract
It has been reported that the thyroid is relatively immune to malignant metastasis. Therefore, in a practical setting, it is difficult to diagnose whether synchronous nodules in both lung and thyroid are independent or have metastasized from one to the other. In the present study, we report a treatment approach in a patient with such nodules, using a molecular technique. A 68-year-old woman presented with synchronous solitary thyroid mass and a nodular lesion in the right lung. Both tumors, which were surgically resected, morphologically showed neuroendocrine differentiation, which was confirmed by immunohistochemical analysis. These features required differential diagnosis from possible (1) medullary thyroid carcinoma (MTC) with metastasis to the lung, (2) pulmonary neuroendocrine carcinoma with metastasis to the thyroid, and (3) independent MTC and pulmonary neuroendocrine carcinoma. Identical mutations of the p53 gene were detected in both the thyroid and lung tumors, indicating the same origin for both tumors. In addition, these mutations and a lack of calcitonin expression suggested a pulmonary origin of the tumors. Metastatic thyroid cancers are well known to cause miliary lesions in the lung, while lung cancers can metastasize to various tissues. Furthermore, pulmonary neuroendocrine carcinoma has been reported as having a tendency of metastasizing to the thyroid. Head and neck surgeons should be aware that a particular subset of lung cancers may develop a metastatic solitary nodule in the thyroid, as presented. An effective therapeutic strategy is largely dependent on the differential diagnosis.
Similar content being viewed by others
References
K Shimaoka JE Sokal JW Pickren et al. (1962) ArticleTitleMetastatic neoplasms in the thyroid gland Cancer 15 557–565 Occurrence Handle13911946 Occurrence Handle10.1002/1097-0142(196205/06)15:3<557::AID-CNCR2820150315>3.0.CO;2-H Occurrence Handle1:STN:280:DyaF387gtlGgug%3D%3D
X Matias-Guiu J LaGuette AM Puras-Gil et al. (1997) ArticleTitleMetastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases Am J Surg Pathol 21 754–762 Occurrence Handle9236831 Occurrence Handle10.1097/00000478-199707000-00003 Occurrence Handle1:STN:280:DyaK2szotVSgsA%3D%3D
WD Travis W Rush D Flieder et al. (1998) ArticleTitleSurvival analysis of 200 pulmonary neuroendocrine tumors: with clarification of criteria for atypical carcinoid and its separation from typical carcinoid Am J Surg Pathol 22 934–944 Occurrence Handle9706973 Occurrence Handle10.1097/00000478-199808000-00003 Occurrence Handle1:STN:280:DyaK1czntVCksg%3D%3D
N Onuki II Wistuba WD Travis et al. (1999) ArticleTitleGenetic changes in the spectrum of neuroendocrine lung tumors Cancer 85 600–607 Occurrence Handle10091733 Occurrence Handle10.1002/(SICI)1097-0142(19990201)85:3<600::AID-CNCR10>3.0.CO;2-W Occurrence Handle1:CAS:528:DyaK1MXht1Wms7o%3D
Y Kitamura K Shimizu K Ito et al. (1998) ArticleTitlep53 gene mutation is not associated with tumorigenesis of medullary thyroid carcinoma Thyroidol Clin Exp 10 171–174
KK Herfarth MR Wick HN Marshall et al. (1997) ArticleTitleAbsence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas Genes Chromosomes Cancer 20 24–29 Occurrence Handle9290950 Occurrence Handle10.1002/(SICI)1098-2264(199709)20:1<24::AID-GCC4>3.0.CO;2-B Occurrence Handle1:CAS:528:DyaK2sXmtFemsrw%3D
AH Redding SN Levine MR Fowler (2000) ArticleTitleNormal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses Thyroid 10 919–922 Occurrence Handle11081258 Occurrence Handle1:STN:280:DC%2BD3M7kt1Ghtg%3D%3D Occurrence Handle10.1089/thy.2000.10.919
M Bockhorn A Frilling S Rewerk et al. (2004) ArticleTitleLack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma Thyroid 14 468–470 Occurrence Handle15242577 Occurrence Handle10.1089/105072504323150813
R Katoh E Miyagi N Nakamura et al. (2000) ArticleTitleExpression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas Hum Pathol 31 386–393 Occurrence Handle10746684 Occurrence Handle10.1016/S0046-8177(00)80255-5 Occurrence Handle1:CAS:528:DC%2BD3cXisFWnsbc%3D
AM Oliveira HD Tazelaar JL Myers et al. (2001) ArticleTitleThyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites Am J Surg Pathol 25 815–819 Occurrence Handle11395561 Occurrence Handle10.1097/00000478-200106000-00015 Occurrence Handle1:STN:280:DC%2BD3Mzislertg%3D%3D
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yamada, H., Hasegawa, Y., Mitsudomi, T. et al. Neuroendocrine tumor metastasis to the thyroid gland. Int J Clin Oncol 12, 63–67 (2007). https://doi.org/10.1007/s10147-006-0628-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-006-0628-8